Abiomed (ABMD) Director Buys 100K Shares
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
Abiomed, Inc. (NASDAQ: ABMD) Director, Henri Termeer, disclosed the purchase of 100,000 shares from 2/22-2/25 at prices from $14.6955-$15.1997, bringing his stake to 172,398 shares.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abiomed (ABMD) Receives Expanded PMA from FDA for Impella Heart Pump
- Abiomed Impella CP Receives Expanded FDA Approval for High-Risk Percutaneous Coronary Intervention (PCI) Procedures
- Point72 Asset Management, L.P. Raises Stake in OPHTHOTECH (OPHT) to 5.0%